Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity

Allergan

Status: Completed

Conditions: Muscle Spasticity

Treatments: Biological: botulinum toxin Type A

Study type: Observational

Funder types: Industry

Identifiers

NCT01387074

MAF/AGN/NS/SPA/018

Details and patient eligibility

About

This is a prospective, non-interventional, observational study to collect data on the use of botulinum toxin Type A in a routine setting in patients with upper limb adult spasticity.

Enrollment: 108 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients with upper limb spasticity following a stroke
• Eligible to receive botulinum toxin Type A
• No previous botulinum toxin Type A therapy

Exclusion criteria

• None

Trial design

108 participants in 1 patient group

botulinum toxin Type A

Description:

Botulinum toxin Type A treatment at a dose determined by the physician at Baseline followed by a second botulinum toxin Type A treatment approximately 12 weeks later if applicable.

Treatment:

Biological: botulinum toxin Type A